{"id":"W4285992810","doi":"10.1056/nejmoa2202809","title":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1096,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck","keywords":"Pembrolizumab; Triple-negative breast cancer; Medicine; Chemotherapy; Breast cancer; Oncology; Internal medicine; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008009161,0.0001687833,0.0006310365,0.0003455083,0.00007178788,0.000004349112,0.0001590429,0.00003805655,0.004472726],"category_scores_gemma":[0.00006813902,0.0001167726,0.0001160252,0.0005239472,0.00009572727,0.0000868455,0.00002020769,0.000615827,6.910743e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000671757,"about_ca_system_score_gemma":0.0007831718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009850165,"about_ca_topic_score_gemma":0.0001481594,"domain_scores_codex":[0.9982145,0.0001184517,0.0006204891,0.0001529759,0.00065562,0.0002379606],"domain_scores_gemma":[0.9990204,0.0001254247,0.0003933515,0.0001502771,0.0001206153,0.0001899506],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1293622,0.0002134053,0.01057292,0.00005135007,0.0003850333,0.0006237005,0.007254011,0.0003546674,0.01925381,0.00002588523,0.01910716,0.8127958],"study_design_scores_gemma":[0.6348619,0.005601054,0.1755899,0.0008417667,0.0001815476,0.01001414,0.002781775,0.0001849624,0.0009405376,0.0004012611,0.168336,0.0002651846],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9302387,0.008312799,0.00006758938,0.05824164,0.001551594,0.0003704772,0.00001875636,0.00001439488,0.001184061],"genre_scores_gemma":[0.9887834,0.003152357,0.0001459043,0.003813027,0.002267319,0.0000123605,0.000004495072,0.00002686762,0.001794274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8125306,"threshold_uncertainty_score":0.9964373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01369630633823049,"score_gpt":0.2953716532372217,"score_spread":0.2816753468989912,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}